Cargando…
Is it time to reform oversight of clinical gene therapy in the EU?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303196/ https://www.ncbi.nlm.nih.gov/pubmed/30341921 http://dx.doi.org/10.1111/bcp.13795 |
| _version_ | 1783382137355894784 |
|---|---|
| author | Kenter, Marcel J.H. |
| author_facet | Kenter, Marcel J.H. |
| author_sort | Kenter, Marcel J.H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6303196 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63031962018-12-31 Is it time to reform oversight of clinical gene therapy in the EU? Kenter, Marcel J.H. Br J Clin Pharmacol Commentary John Wiley and Sons Inc. 2018-11-13 2019-01 /pmc/articles/PMC6303196/ /pubmed/30341921 http://dx.doi.org/10.1111/bcp.13795 Text en © 2018 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Commentary Kenter, Marcel J.H. Is it time to reform oversight of clinical gene therapy in the EU? |
| title | Is it time to reform oversight of clinical gene therapy in the EU? |
| title_full | Is it time to reform oversight of clinical gene therapy in the EU? |
| title_fullStr | Is it time to reform oversight of clinical gene therapy in the EU? |
| title_full_unstemmed | Is it time to reform oversight of clinical gene therapy in the EU? |
| title_short | Is it time to reform oversight of clinical gene therapy in the EU? |
| title_sort | is it time to reform oversight of clinical gene therapy in the eu? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303196/ https://www.ncbi.nlm.nih.gov/pubmed/30341921 http://dx.doi.org/10.1111/bcp.13795 |
| work_keys_str_mv | AT kentermarceljh isittimetoreformoversightofclinicalgenetherapyintheeu |